Literature DB >> 31851856

Inhibition of immunothrombosis does not affect pathogen capture and does not promote bacterial dissemination in a mouse model of sepsis.

Agostina Carestia1, Rachelle P Davis1, Lauren Davis2, Craig N Jenne1.   

Abstract

After infection, neutrophils release neutrophil extracellular traps (NETs), decondensed DNA fibers decorated with both nuclear proteins and proteins derived from intracellular granules. These structures have a fundamental role in the development of immunothrombosis; a physiological process mediated by immune cells and molecules from the coagulation system that facilitates the recognition, containment, and destruction of pathogens. Although NETs and immunothrombi are widely hypothesized to be key host defense responses responsible for limiting bacterial dissemination, their actual role in this process has not been formally assessed within the context of a bloodstream infection. Mice were first treated with LPS to generate inflammation (NETs and immunothrombi) and then bacteria dissemination was analyzed by intravital microscopy and colony-forming units (CFU) assay. Blocking NETs or coagulation by the administration of DNase or Argatroban (thrombin inhibitor), respectively, did not modify the percentage of bacteria capture by Kupffer cells, neutrophils or platelets. Moreover, both inhibitors reduced the number of bacteria in the spleen, without modifying CFUs in the liver or lung. In conclusion, we demonstrate that immunothrombi are not necessary to limit the dissemination of bloodstream bacterial infections.

Entities:  

Keywords:  Bacteria; coagulation; immunotrhombosis; infection; neutrophil extracellular traps; neutrophils

Mesh:

Year:  2019        PMID: 31851856     DOI: 10.1080/09537104.2019.1704711

Source DB:  PubMed          Journal:  Platelets        ISSN: 0953-7104            Impact factor:   3.862


  7 in total

1.  Generation of neutrophil extracellular traps in patients with acute liver failure is associated with poor outcome.

Authors:  Fien A von Meijenfeldt; R Todd Stravitz; Jingwen Zhang; Jelle Adelmeijer; Yoh Zen; Valerie Durkalski; William M Lee; Ton Lisman
Journal:  Hepatology       Date:  2021-12-12       Impact factor: 17.298

2.  Gasdermin D-dependent platelet pyroptosis exacerbates NET formation and inflammation in severe sepsis.

Authors:  Meiling Su; Chaofei Chen; Ping Wang; John Hwa; Wai Ho Tang; Shaoying Li; Musheng Li; Zhi Zeng; Yuan Zhang; Luoxing Xia; Xiuzhen Li; Dezhong Zheng; Qiqi Lin; Xuejiao Fan; Ying Wen; Yingying Liu; Feiyan Chen; Wei Luo; Yun Bu; Jinhong Qin; Manli Guo; Miaoyun Qiu; Lei Sun; Renjing Liu
Journal:  Nat Cardiovasc Res       Date:  2022-08-04

3.  Neutrophil extracellular trap inhibition improves survival in neonatal mouse infectious peritonitis.

Authors:  Frederik Denorme; John L Rustad; Irina Portier; Jacob L Crandell; Claudia V de Araujo; Mark J Cody; Robert A Campbell; Christian C Yost
Journal:  Pediatr Res       Date:  2022-07-28       Impact factor: 3.953

4.  Unravelling the Role of Neutrophil Extracellular Traps in Acute Liver Failure.

Authors:  Fien A von Meijenfeldt; Ton Lisman
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2022-06-29

Review 5.  Thromboprophylaxis with argatroban in critically ill patients with sepsis: a review.

Authors:  Mirjam Bachler; Lars M Asmis; Jürgen Koscielny; Thomas Lang; Hartmuth Nowak; Patrick Paulus; Jens-Christian Schewe; Christian von Heymann; Dietmar Fries
Journal:  Blood Coagul Fibrinolysis       Date:  2022-06-08       Impact factor: 1.061

Review 6.  Extracellular DNA-A Danger Signal Triggering Immunothrombosis.

Authors:  Chongxu Shi; Luying Yang; Attila Braun; Hans-Joachim Anders
Journal:  Front Immunol       Date:  2020-10-07       Impact factor: 7.561

Review 7.  Staphylococcus aureus and Neutrophil Extracellular Traps: The Master Manipulator Meets Its Match in Immunothrombosis.

Authors:  Severien Meyers; Marilena Crescente; Peter Verhamme; Kimberly Martinod
Journal:  Arterioscler Thromb Vasc Biol       Date:  2022-02-03       Impact factor: 8.311

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.